Zomedica Announces Achievement of Therapeutic Development Milestones
December 12, 2017 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Ritter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose Intolerance
October 03, 2017 12:00 ET
|
Ritter Pharmaceuticals
Los Angeles, California,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutic products...
FDA Commissioner Scott Gottlieb to Deliver Keynote at RAPS Regulatory Convergence
July 03, 2017 09:00 ET
|
Regulatory Affairs Professionals Society (RAPS)
Rockville, MD, USA, July 03, 2017 (GLOBE NEWSWIRE) -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, will address the global regulatory community on 10 September, delivering...
Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
June 19, 2017 16:30 ET
|
Melinta Therapeutics
- Baxdela offers a new option for treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) including hospital-treated skin infections in oral and IV formulations as...
Melinta Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Topical Radezolid
February 28, 2017 08:00 ET
|
Melinta Therapeutics
NEW HAVEN, Conn., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced today the U.S. Food...
CapsoVision, Inc. Announces FDA 510(k) Clearance for CapsoCam® Plus
November 11, 2016 15:43 ET
|
CapsoVision Inc.
SARATOGA, Calif., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Silicon Valley medical device innovator CapsoVision, Inc. is pleased to announce that they have received U.S. Food and Drug Administration (FDA)...
Medstar Union Memorial Hospital Makes Pioneering Strides in Coronary Care
August 08, 2016 17:53 ET
|
MedStar Health
BALTIMORE, MD--(Marketwired - August 08, 2016) - MedStar Union Memorial Hospital became the first and only hospital in Maryland to offer a fully dissolvable cardiac stent to patients fighting coronary...
American College of Rheumatology Encourages Safe Adoption of Biosimilars During FDA Public Hearing on CT-P13, a Proposed Biosimilar for Infliximab (Remicade)
February 10, 2016 14:43 ET
|
American College of Rheumatology
ATLANTA, Feb. 10, 2016 (GLOBE NEWSWIRE) -- During a public meeting held Tuesday by the Food and Drug Administration (FDA)'s Arthritis Advisory Committee to review the license application of CT-P13,...
ENT and Allergy Associates(R) Announce ImThera Medical Clinical Study
May 28, 2015 14:48 ET
|
Ent and Allergy
TARRYTOWN, N.Y., May 28, 2015 (GLOBE NEWSWIRE) -- The following is a message from Dr. Ofer Jacobowitz, partner of ENT and Allergy Associates:
Sleep apnea is a serious and dangerous disease where...
Relmada Therapeutics Set for Busy 2015 in Clinical Trials Developing Drugs for the Lucrative Pain Market
April 02, 2015 08:30 ET
|
Relmada Therapeutics, Inc.
NEW YORK, NY--(Marketwired - April 02, 2015) - Relmada Therapeutics, Inc. (OTCQB: RLMD) has quite a busy 2015 ahead of it in the clinic. The pharmaceutical company has stepped up its work in a big...